Focus on venous thromboembolism during pregnancy

doi:10.3969/j.issn.1004-583X.2016.04.004

Abstract

Abstract: Venous thromboembolism (VTE) is constituted by pulmonary thromboembolism (PTE) and deep venous thrombosis (DVT). Blood hypercoagulable, along with vascular damage and stasis during pregnancy and puerperium contribute to a high incidence of VTE. In clinically suspected VTE, anticoagulation therapy should be commenced immediately until the diagnosis is excluded by objective testing, unless treatment is strongly contraindicated. Low molecular weight heparin (LMWH) does not pass through the placenta and is safe in breastfeeding, hence will be the best choice for pregnancy and puerperium. Treatment with LMWH should be employed during the remainder of the pregnancy and last for at least 6 weeks postnatally and at least 3 months of treatment will be necessary.

Key words: venous thromboembolism, pregnancy, pulmonary embolism, venous thrombosis

CLC Number:

R619.2

Li Hongwei, Wu Qi. Focus on venous thromboembolism during pregnancy[J]. Clinical Focus, 2016, 31(4): 359-362.

Add to citation manager EndNote|Ris|BibTeX

URL: https://huicui.hebmu.edu.cn/EN/10.3969/j.issn.1004-583X.2016.04.004

https://huicui.hebmu.edu.cn/EN/Y2016/V31/I4/359

References

[1] Konstantinides SV, Torbicki A, Agnelli G, et al. 2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism[J]. Eur Heart J, 2014, 35(43):3033-3069, 3069a-3069k.
[2] Regitz-Zagrosek V, Lundqvist CB, Borghi C, et al. ESC Guidelines on the management of cardiovascular diseases during pregnancy: the Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC)[J]. Eur Heart J, 2011, 32(24):3147-3197.
[3] Thromboembolic disease in Pregnancy and the Puerperium: Acute Management[Z]. RCOG Green-top Guideline No. 37b, 2015.[4] James A. Practice bulletin no. 123: thromboembolism in pregnancy[J]. Obstet Gynecol, 2011, 118(3): 718-729.
[5] Bourjeily G, Paidas M, Khalil H, et al. Pulmonary embolism in pregnancy[J]. Lancet,2010,375(9713):500-512.
[6] 许欣, 杜军. 急性肺栓塞症的诊治进展[J]. 临床荟萃, 2013, 28(6):699-702.
[7] Blanco-Molina A, Rota LL, Micco PD, et al. Venous thromboembolism during pregnancy, postpartum or during contraceptive use[J]. Thromb Haemost, 2010, 103(2):306-311.
[8] Leung AN, Bull TM, Jaeschke R, et al. An official American Thoracic Society/Society of Thoracic Radiology clinical practice guideline: evaluation of suspected pulmonary embolism in pregnancy[J]. Am J Respir Crit Care Med, 2011, 184(10):1200-1208.
[9] Gal GL, Kercret G, Yahmed KB, et al. Diagnostic value of single complete compression ultrasonography in pregnant and postpartum women with suspected deep vein thrombosis: prospective study[J]. BMJ, 2012, 344(16):e2635.
[10] Chan WS, Spencer FA, Lee AY, et al. Safety of withholding anticoagulation in pregnant women with suspected deep vein thrombosis following negative serial compression ultrasound and iliac vein imaging[J]. CMAJ, 2013, 185(4):E194-200.
[11] Nguyen CP, Goodman LH. Fetal Risk in Diagnostic Radiology[J]. Semin Ultrasound CT MR, 2012, 33(1):4-10.
[12] Stein PD, Fowler SE, Goodman LR, et al. Multidetector computed tomography for acute pulmonary embolism[J]. N Engl J Med, 2006,354(22): 2317-2327.
[13] Scarsbrook AF, Evans AL, Owen AR, et al. Diagnosis of suspected venous thromboembolic disease in pregnancy[J]. Clin Radiol, 2006, 61(1):1-12.
[14] Knol HM, Schultinge L, Veeger NJ, et al. The risk of postpartum haemorrhage in women using high dose of low-molecular-weight heparins during pregnancy[J]. Thromb Res, 2012, 130(3):334-338.
[15] Greer IA, Catherine NP. Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: a systematic review of safety and efficacy[J]. Blood, 2005,106(2):401-407.
[16] Bates SM, Greer IA, Saskia M, et al. VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines[J]. Chest, 2012, 141(Part Ⅱ):e691S-736S.
[17] Christof S, Doreen H, Reinhard M, et al. Vitamin K antagonists and pregnancy outcome. A multi-centre prospective study[J]. Thromb Haemost, 2006, 95(6):949-957.
[18] Tang AW, Greer I. A systematic review on the use of new anticoagulants in pregnancy[J]. Obstetric Medicine, 2013, 6(2):64-71.
[19] Richter C, Jrg Sitzmann, Lang P, et al. Excretion of low molecular weight heparin in human milk[J]. Br J Clin Pharmacol, 2001, 52(6):708-710.
[20] Clark SL, Porter TF, West FG. Coumarin derivatives and breast-feeding[J]. Obstet Gynecol, 2000, 95(6Pt1):938-940.